Dr. Claudia SŁssmuth Dyckerhoff is a Venture Partner at Qiming Venture Partners, focusing on healthcare investments. Claudia has been with McKinsey for 21 years in Europe, the US and for more than 10 years in Asia.
She became a Board member of Hoffmann-La Roche in May 2016, a Board member of Clariant in April 2016, a Board Member of Ramsay Health Care (international hospital operator) in November 2018 and she joined the QuEST Global board in November 2020. At Hoffmann-La Roche she is a member of the Corporate Governance and Sustainability Committee, at Clariant she is a member of the Compensation Committee and at Ramsay Health Care she is a member of the Risk Committee. For McKinsey, she remains in the role of a Senior Advisor.
She also supports two start-ups, and in September 2017 joined the board of Cyrcadia, a med tech start-up.
She joined McKinsey & Company in Switzerland 1995 with a transfer to the US focusing her work on supporting Healthcare companies - pharmaceutical/medical device companies, payor, provider and health systems in Europe and the US. In January 2006, she and her family transferred to China where she supported the buildup of the Healthcare sector Ė supporting Pharma and Med Tech companies in strategic as well as operative topics. As a Senior Partner, she took on the leadership of McKinseyís Asia wide Health Systems and Services Sector serving healthcare companies as well as governments. Most of her recent work focuses on market entry or market growth strategies, business development, assessment of potential privatization assets in the health services arena, commercial excellence, organizational redesign and capability building, and operational performance improvement in hospitals. Claudia studied Business Administration at the University of St. Gallen, Switzerland as well as at ESADE, Barcelona where she graduated with an MBA.
She also holds a PhD in Business Administration from the University of St. Gallen/University of Michigan Ann Arbor.